Ioannou, N., Dalgleish, A. G., Seddon, A. M., Mackintosh, D., Guertler, U., Solca, F., & Modjtahedi, H. (2011). Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. British Journal of Cancer, 105(10), 1554. https://doi.org/10.1038/bjc.2011.396
Chicago Style (17th ed.) CitationIoannou, N., A G. Dalgleish, A M. Seddon, D. Mackintosh, U. Guertler, F. Solca, and H. Modjtahedi. "Anti-tumour Activity of Afatinib, an Irreversible ErbB Family Blocker, in Human Pancreatic Tumour Cells." British Journal of Cancer 105, no. 10 (2011): 1554. https://doi.org/10.1038/bjc.2011.396.
MLA (9th ed.) CitationIoannou, N., et al. "Anti-tumour Activity of Afatinib, an Irreversible ErbB Family Blocker, in Human Pancreatic Tumour Cells." British Journal of Cancer, vol. 105, no. 10, 2011, p. 1554, https://doi.org/10.1038/bjc.2011.396.